Simplex Trading’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23
Closed -$47 – 9695
2026
Q2
$37 Sell
23
-3,343
-99% -$4.62K ﹤0.01% 9136
2026
Q1
$3.8K Sell
3,366
-4,623
-58% -$6.59K ﹤0.01% 8057
2025
Q4
$12.5K Sell
7,989
-4,519
-36% -$8.06K ﹤0.01% 6842
2025
Q3
$25K Sell
12,508
-57,835
-82% -$132K ﹤0.01% 7137
2025
Q2
$162K Buy
70,343
+27,534
+64% +$202K ﹤0.01% 4729
2025
Q1
$334K Buy
+42,809
New +$340K ﹤0.01% 3828
2024
Q3
– Sell
-5,786
Closed -$41.1K – 8982
2024
Q2
$51K Buy
+5,786
New +$57K ﹤0.01% 6062
2024
Q1
– Sell
-2,090
Closed -$25.3K – 9306
2023
Q4
$23K Sell
2,090
-9,999
-83% -$83.8K ﹤0.01% 6802
2023
Q3
$81K Buy
12,089
+9,299
+333% +$77.1K ﹤0.01% 5303
2023
Q2
$25K Buy
2,790
+650
+30% +$5.22K ﹤0.01% 6538
2023
Q1
$13K Sell
2,140
-667
-24% -$5.37K ﹤0.01% 7309
2022
Q4
$17K Buy
2,807
+628
+29% +$4.46K ﹤0.01% 7032
2022
Q3
$13K Sell
2,179
-4,113
-65% -$36.1K ﹤0.01% 7990
2022
Q2
$55K Sell
6,292
-16,823
-73% -$125K ﹤0.01% 6365
2022
Q1
$194K Buy
23,115
+20,805
+901% +$187K ﹤0.01% 5196
2021
Q4
$23K Sell
2,310
-5,056
-69% -$74.9K ﹤0.01% 8198
2021
Q3
$135K Buy
7,366
+600
+9% +$11.6K ﹤0.01% 6189
2021
Q2
$118K Buy
+6,766
New +$91.2K ﹤0.01% 6489

Other funds holding INMB

Simplex Trading's INMB Position: Q3 2026 in Review

Simplex Trading sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 23 shares — an estimated $47 sold.

Simplex Trading first reported a position in INMB in Q2 2021 and held it in 18 quarters. The position peaked at $334K in Q1 2025. 46 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Simplex Trading reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
  • Simplex Trading sold 23 INmune Bio shares in Q3 2026, an estimated $47.
  • Simplex Trading first reported a position in INmune Bio in Q2 2021 and held it in 18 quarters.
  • Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
  • 46 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.